{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:19:04Z","timestamp":1792293544494,"version":"4.4.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Ectopic Cushing syndrome secondary to corticotropin releasing hormone (CRH)\u2013secreting tumors or CRH and adrenocorticotropin hormone cosecreting tumors is extremely rare. We report here the case of a 54-year-old man who experienced CRH-secreting pancreatic neuroendocrine tumor causing Cushing syndrome, initially detected by SSTR (somatostatin receptor) scintigraphy, then significantly progressed with multiple liver metastases, demonstrating significantly increased SSTR expression on <jats:sup>68<\/jats:sup>Ga-DOTATOC PET\/CT and a \u201cmismatch\u201d imaging pattern on <jats:sup>18<\/jats:sup>F-FDG PET\/CT. The patient underwent peptide receptor radionuclide therapy with <jats:sup>177<\/jats:sup>Lu\/<jats:sup>90<\/jats:sup>Y-DOTATOC and demonstrated excellent response to the treatment.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002834","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T10:14:49Z","timestamp":1573553689000},"page":"e125-e127","source":"Crossref","is-referenced-by-count":6,"title":["Ectopic Corticotropin-Releasing Hormone\u2013Secreting Pancreatic Neuroendocrine Tumor"],"prefix":"10.1097","volume":"45","author":[{"given":"Jingjing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshad R.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/17843286.2017.1373927","article-title":"Paraneoplastic Cushing syndrome, case-series and review of the literature","volume":"73","year":"2018","journal-title":"Acta Clin Belg"},{"key":"bib2-20230925","first-page":"1","article-title":"Ectopic Cushing's syndrome due to corticotropin releasing hormone","volume":"2019","journal-title":"Pituitary"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00259-018-4228-4","article-title":"Ectopic corticotropin-releasing hormone syndrome caused by pancreatic neuroendocrine tumor localized by 68Ga-DOTATATE PET\/CT","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/jc.2014-2945","article-title":"Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing Cushing syndrome: a diagnostic dilemma and how to solve it","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/RLU.0000000000000806","article-title":"Ectopic ACTH and CRH co-secreting tumor localized by 68Ga-DOTA-TATE PET\/CT","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"R551","DOI":"10.1530\/ERC-16-0151","article-title":"Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future","volume":"23","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"16932","DOI":"10.18632\/oncotarget.24524","article-title":"Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms","volume":"9","year":"2018","journal-title":"Oncotarget"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7150\/thno.13702","article-title":"[(177)Lu-DOTA](0)-D-Phe(1)-Tyr(3)-Octreotide ((177)Lu-DOTATOC) for peptide receptor radiotherapy in patients with advanced neuroendocrine tumours: a phase-II study","volume":"6","year":"2016","journal-title":"Theranostics"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","year":"2009","journal-title":"Eur J Cancer"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group","volume":"35","year":"1999","journal-title":"Eur J Cancer"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:07:01Z","timestamp":1695622021000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002834"}},"subtitle":["Excellent Response of Liver Metastases to Peptide Receptor Radionuclide Therapy as Demonstrated by 68Ga-DOTATOC and 18F-FDG PET\/CT Imaging"],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002834","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,11]]}}}